Cargando…
The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes
Diabetes mellitus encompasses two distinct disease processes: autoimmune Type 1 (T1D) and nonimmune Type 2 (T2D) diabetes. Despite the disparate aetiologies, the disease phenotype of hyperglycemia and the associated complications are similar. In this paper, we discuss the role of the CD39-adenosiner...
Autores principales: | Chia, Joanne S. J., McRae, Jennifer L., Cowan, Peter J., Dwyer, Karen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480695/ https://www.ncbi.nlm.nih.gov/pubmed/23118504 http://dx.doi.org/10.1155/2012/320495 |
Ejemplares similares
-
The Protective Effects of CD39 Overexpression in Multiple Low-Dose Streptozotocin–Induced Diabetes in Mice
por: Chia, Joanne S.J., et al.
Publicado: (2013) -
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
The Adenosinergic System in Diabetic Retinopathy
por: Vindeirinho, J., et al.
Publicado: (2016) -
Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
por: Horenstein, Alberto L., et al.
Publicado: (2018) -
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
por: Horenstein, Alberto L, et al.
Publicado: (2013)